Institute of Clinical Research India (ICRI) files case against CRI for illegal brand use

from using the trade mark CRI or the name Clinical Research Institute (India) in connection with its business activities by the Honble Delhi High Court.The order read as: The defendant is restrained from using the trademark CRI or the name Clinical Research Institute (India) in connection with its business activities. ICRI had approached Honble High Court of Delhi for grant of Permanent Injunction and other relief vide suit no 270 of 2008 against Mr Vijay Moza, founder of CRI, from using the mark and name CRI and Clinical Research Institute (India) as it violated the Trademark of ICRI and also was deceptively similar to its name i.e. Institute of Clinical Research (India) .

According to ICRI, Mr Moza was an employee of ICRI and served the company as its CEO and Executive Director. He later resigned from the services of ICRI. However he started using a mark and name deceptively similar to ICRI. ICRI says it did not have any alternative but to take appropriate action in a court of law to protect its Trademark and Name from being used inappropriately and approached the Honble High Court of Delhi. ICRI is Indias premier Clinical Research Institute.

ICRI has been conceived with the objective of meeting the growing demand of skilled Clinical Research professionals in the future. The choice of courses offered by the Institution is specially made to suit the requirements of a large number of people with varied experiences.ICRI currently operates from four campuses in Mumbai, Delhi, Ahmedabad and Bangalore. It offers a Full time course 2 years M.Sc in Clinical Research program and also a Post Graduate Diploma in Advanced Clinical Research. ICRI is also slated to open Campuses in Singapore, US in 2008.